ClassID:

20908

A61K38/14 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin

Recent Application in this class:
#1
20260151553
2026-06-04

METHOD SYSTEM AND APPARATUS FOR DRUG DELIVERY AND TREATMENT

#2
20260146046
2026-05-28

BICYCLIC FERROPORTIN INHIBITORS

#3
20260137671
2026-05-21

PDK4 as a Cell-Aging Intervention Target and Its Use in Chemotherapy and Anticancer

#4
20260137650
2026-05-21

MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)

#5
20260124237
2026-05-07

CARTILAGE REGENERATION COMPOSITION

#6
20260102460
2026-04-16

NOVEL COMBINATIONS OF ANTIBIOTICS AND NON-ANTIBIOTIC DRUGS EFFECTIVE IN VIVO AGAINST GRAM-POSITIVE BACTERIA, IN PARTICULAR METHICILLIN-RESISTANT S. AUREUS (MRSA)

#7
20260102439
2026-04-16

Methods for Treating a Health Condition with Probiotics

#8
20260091002
2026-04-02

COMPOSITION FOR ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY CONTAINING HALOGENATED PHENOL DERIVATIVE AS ACTIVE INGREDIENT

#9
20260076734
2026-03-19

Method and Device for Whole Organ Pulsed Electric Field Application for Irreversible Electroporation

#10
20260069538
2026-03-12

CXCR4 ANTAGONIST LOADED LIPOSOMES AND SILICASOMES

#11
20260053887
2026-02-26

Methods and Kits to Prevent And/Or Treat Cardiac Disorders

#12
20260053845
2026-02-26

LIPOSOMAL FORMULATION AND USE IN A COMBINATION PRODUCT AS AN ANTI-TUMOUR THERAPY

#13
20260048118
2026-02-19

COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING

#14
20260041712
2026-02-12

VACCINE ADJUVANTS AND FORMULATIONS

#15
20260034183
2026-02-05

TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION

#16
20260027166
2026-01-29

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#17
20260027040
2026-01-29

METHOD OF USING AQUEOUS SOLUTION OF PROPYLENE GLYCOL TO INHIBIT DEGRADATION OF DALBAVANCIN HYDROCHLORIDE, DALBAVANCIN INJECTION FORMULATION, PREPARATION METHOD AND METHOD OF USING THE SAME

#18
20250387488
2025-12-25

ACTIVE AGENT-ELUTING HEMOSTATIC AGENTS AND METHODS OF USE THEREOF

#19
20250375486
2025-12-11

REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS

#20
20250367363
2025-12-04

METHODS OF LOCAL IRRIGATION FOR TREATING INFECTIONS

#21
20250360262
2025-11-27

IRRIGATION SYSTEM AND METHODS OF USE

#22
20250352610
2025-11-20

NOVEL COMPOSITION

#23
20250345438
2025-11-13

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#24
20250325590
2025-10-23

METHOD OF TREATING AN INDIVIDUAL WITH A HEALTH CONDITION WITH FECAL MICROBIOTA TRANSPLANT

#25
20250325481
2025-10-23

METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS

#26
20250302989
2025-10-02

STING AGONIST-CONTAINING UREASE-POWERED NANOMOTOR-BASED BLADDER CANCER IMMUNOTHERAPY AGENT

#27
20250302768
2025-10-02

NANOPARTICLE DOPED POLYETHYLENE GLYCOL BASED GELS AND MEDICAL DEVICES FOR DRUG DELIVERY

#28
20250302745
2025-10-02

COMPOSITIONS COMPRISING VANCOMYCIN

#29
20250295729
2025-09-25

NOVEL THERAPEUTIC METHODS OF USING PEPTIDOGLYCAN MUROPEPTIDES TO PROMOTE ATP SYNTHASE ACTIVITY AND MITOCHONDRIAL HOMEOSTASIS AND DEVELOPMENT

#30
20250295619
2025-09-25

Use of Salvianolic Acid E in the Preparation of Drugs Targeting Senescent Cells, Inhibiting Tumors or Extending Lifespan

#31
20250288640
2025-09-18

GLYCOPEPTIDE COMPOSITIONS

#32
20250283898
2025-09-11

ALPHA DEFENSIN ASSAY FOR DIAGNOSING NOSOCOMIAL VENTRICULITIS

#33
20250281271
2025-09-11

TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE

#34
20250276072
2025-09-04

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

#35
20250276065
2025-09-04

Electro Magnetic Transducer Network in the Enhancement of Anti-infective Strategies

#36
20250262147
2025-08-21

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

#37
20250241900
2025-07-31

METHODS OF LOCAL IRRIGATION FOR TREATING FUNGAL INFECTIONS

#38
20250222066
2025-07-10

COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION

#39
20250195660
2025-06-19

INACTIVATING BACTERIA WITH ELECTRIC PULSES AND ANTIBIOTICS

#40
20250177586
2025-06-05

HEATING APPARATUS AND METHODS

#41
20250177376
2025-06-05

ALPHA 2 ADRENERGIC RECEPTOR BLOCKADE FOR THE TREATMENT OF C. DIFFICILE COLITIS

#42
20250170227
2025-05-29

CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF

#43
20250152936
2025-05-15

METHOD FOR THE TREATMENT OF VASCULAR ANOMALIES BY ADMINISTERING ONE OR MORE SCLEROSING AGENTS AND APPLYING A SERIES OF ELECTRIC PULSES

#44
20250152661
2025-05-15

NOVEL COMBINATION TREATMENT REGIMEN OF BACTERIAL INFECTIONS

#45
20250135005
2025-05-01

PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES

#46
20250114430
2025-04-10

MODIFIED PEPTIDOMIMETICS AND METHODS OF USE

#47
20250099557
2025-03-27

ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION

#48
20250099535
2025-03-27

GEPOTIDACIN AND VANCOMYCIN FOR USE IN THE TREATMENT OF AN INFECTION CAUSED BY STAPHYLOCOCCUS SAPROPHYTICUS

#49
20250073233
2025-03-06

MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)

#50
20250064835
2025-02-27

A COMPOSITION FOR TREATING OCULAR INFECTIONS AND A METHOD OF PREPARATION THEREOF

#51
20250049819
2025-02-13

METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION

#52
20250042961
2025-02-06

P53 PEPTIDOMIMETIC MACROCYCLES

#53
20250032699
2025-01-30

MEDICAL DEVICE FOR PREVENTING SURGICAL INFECTION

#54
20250032575
2025-01-30

USE OF A MURAMYL PEPTIDE IN THE TREATMENT OF SKELETAL GROWTH RETARDATION

#55
20250032515
2025-01-30

COMPOSITIONS AND METHODS OF CLOSTRIDIODIDES DIFFICILE TREATMENT, DECOLONIZATION, AND PREVENTION

#56
20250025629
2025-01-23

IRRIGATION SYSTEM AND METHODS OF USE

#57
20250017848
2025-01-16

CARRIER OR AUXILIARY MATERIAL OF OPHTHALMIC PREPARATION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#58
20250009838
2025-01-09

FORMULATIONS OF VANCOMYCIN

#59
20240415880
2024-12-19

Treatment of Breast and Other Cancers Using Zinc Chloride Instead of Radiation

#60
20240408070
2024-12-12

COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM

#61
20240398719
2024-12-05

CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS

#62
20240390470
2024-11-28

Non-Toxin Antigens For Clostridioides Difficile Vaccine

#63
20240390300
2024-11-28

ADVANCED METHOD AND KIT FOR WOUND TREATMENT

#64
20240382596
2024-11-21

COMPOSITION OF VANCOMYCIN AQUEOUS SOLUTION

#65
20240374655
2024-11-14

INTESTINAL MICROBIOTA AND GVHD

#66
20240358844
2024-10-31

THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS

#67
20240358792
2024-10-31

LIQUID DALBAVANCIN COMPOSITIONS

#68
20240358638
2024-10-31

FOAM COMPOSITIONS FOR TREATING CLOSTRIDIOIDES DIFFICILE INFECTIONS

#69
20240351967
2024-10-24

METHODS OF PREPARATION OF ZINGERONE, COMPOSITIONS COMPRISING ZINGERONE, AND USES THEREFOR

#70
20240301505
2024-09-12

URINARY TRACT CANCER TREATMENT GUIDED BY MUTATIONAL LANDSCAPE

#71
20240299368
2024-09-12

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#72
20240277799
2024-08-22

Translational Activators, Including Methods of Discovery and Uses Thereof

#73
20240269247
2024-08-15

Microbiome protection from oral antibiotics

#74
20240226000
2024-07-11

TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS

#75
20240199698
2024-06-20

PEPTIDE AMPHIPHILE COMPOSITIONS AND METHODS OF USE THEREOF

#76
20240197842
2024-06-20

METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS

#77
20240189319
2024-06-13

RIFAMYCIN ANALOGS IN COMBINATION WITH VANCOMYCIN AND USES THEREOF

#78
20240182566
2024-06-06

Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS

#79
20240173365
2024-05-30

METHODS OF COLONIZING A MICROBIOME, TREATING AND/OR PREVENTING INFLAMMATORY BOWEL DISEASE AND GRAFT VERSUS HOST DISEASE

#80
20240173360
2024-05-30

COMPOSITIONS AND METHODS FOR TREATING EPILEPSY AND RELATED DISORDERS

#81
20240165620
2024-05-23

FLUIDIC DEVICE FOR THE DETECTION, CAPTURE, OR REMOVAL OF A DISEASE MATERIAL

#82
20240139282
2024-05-02

Liquid dalbavancin compositions

#83
20240139281
2024-05-02

USE OF GOJI GLYCOPEPTIDE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS

#84
20240130962
2024-04-25

TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS

#85
20240123000
2024-04-18

TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION

#86
20240115658
2024-04-11

Use of an intervertebral disc fibrosis-inducing substance in preparation of medication

#87
20240108685
2024-04-04

ORAL LIPOSOMAL COMPOSITIONS

#88
20240108572
2024-04-04

Implantable cellular and biotherapeutic agent delivery canister

#89
20240091416
2024-03-21

COMPOSITION FOR PRODUCING A BONE REPLACEMENT MATERIAL, METHOD FOR PRODUCING A PHARMACEUTICAL EXCIPIENT, PHARMACEUTICAL EXCIPIENT, AND USE THEREOF

#90
20240091400
2024-03-21

ANTIMICROBIAL DRESSING FOR WOUNDS

#91
20240082346
2024-03-14

Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the Same

#92
20240075075
2024-03-07

REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS

#93
20240066135
2024-02-29

DRUG CONJUGATES AND USES THEREOF

#94
20240066128
2024-02-29

Inactivating bacteria with electric pulses and antibiotics

#95
20240066022
2024-02-29

DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION

#96
20240066010
2024-02-29

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#97
20240058453
2024-02-22

Click chemistry hydrogel with minimal swelling as a dural sealant and local delivery vehicle for recombinant proteins and other bioactive agents

#98
20240041997
2024-02-08

VACCINE ADJUVANTS AND FORMULATIONS

#99
20240033354
2024-02-01

A BROADLY NEUTRALIZING MOLECULE AGAINST CLOSTRIDIUM DIFFICILE TOXIN B

#100
20240033228
2024-02-01

MESOPOROUS NANOPARTICLES SYSTEM TO INCREASE THE BIOFILM ERADICATION ACTIVITY BY MEANS OF THE CARRYING AND THE ADMINISTRATION OF AT LEAST ONE ACTIVE INGREDIENT AND RELATED PRODUCTION METHOD

#101
20240024412
2024-01-25

PHARMACEUTICAL COMPOSITION FOR TREATING CDI COMPRISING CLAY MINERAL COMPLEX, AND METHOD FOR PRODUCING SAME

#102
20240024411
2024-01-25

METHODS FOR THE PREVENTION OR TREATMENT OF ANTHRAX INFECTION

#103
20240016945
2024-01-18

Composition and method for new antimicrobial agents with secondary mode of action provided by conjugation of an antimicrobial to a guanidinium-rich molecular transporter

#104
20240009246
2024-01-11

CELLULAR-ANTIMICROBIAL COMBINATION COMPOSITION AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS OF JOINTS AND SOFT TISSUES

#105
20240000884
2024-01-04

AQUEOUS SOLUTION

#106
20240000862
2024-01-04

REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS

#107
20230414773
2023-12-28

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

#108
20230414682
2023-12-28

Methods for Treating a Health Condition with Probiotics

#109
20230414584
2023-12-28

ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS

#110
20230405099
2023-12-21

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

#111
20230404983
2023-12-21

COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER

#112
20230404921
2023-12-21

LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE

#113
20230398194
2023-12-14

METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE

#114
20230372438
2023-11-23

Formulations of vancomycin

#115
20230372362
2023-11-23

METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION

#116
20230355520
2023-11-09

METHODS AND COMPOSITIONS FOR TREATING DIABETIC FOOT ULCERS

#117
20230346712
2023-11-02

MEDICINE LOADED NANO-CAPSULE ADDITIVE PMMA CEMENT

#118
20230338464
2023-10-26

USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATION

#119
20230338314
2023-10-26

METHODS FOR THE TREATMENT OF MYELOID DERIVED SUPPRESSOR CELLS RELATED DISORDERS

#120
20230330071
2023-10-19

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#121
20230330020
2023-10-19

MEDICATION THAT PROTECTS THE INTESTINAL MICROBIOTA AND THEIR PREPARATION METHODS AND APPLICATIONS

#122
20230321251
2023-10-12

LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT

#123
20230303964
2023-09-28

ANTIVIRAL TREATMENT COMPRISING BLIS CONTAINING PROBIOTIC PRODUCTS

#124
20230301907
2023-09-28

COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID

#125
20230293628
2023-09-21

MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS

#126
20230277658
2023-09-07

COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING

#127
20230277632
2023-09-07

MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA

#128
20230277471
2023-09-07

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

#129
20230270830
2023-08-31

Microbiome protection from oral antibiotics

#130
20230250196
2023-08-10

CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE

#131
20230248771
2023-08-10

PLATELETS LOADED WITH ANTI-CANCER AGENTS

#132
20230241158
2023-08-03

Hydrophilic Degradable Microspheres for Local Delivering of Glycopeptide Antibiotics and Polycationic Peptide Antibiotics

#133
20230233536
2023-07-27

RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA

#134
20230226190
2023-07-20

Compositions and methods for delivering an agent to a wound

#135
20230226129
2023-07-20

ELIMINATION OF COLONIC BACTERIAL DRIVING LETHAL INFLAMMATORY CARDIOMYOPATHY

#136
20230218529
2023-07-13

Methods for continuous manufacture of liposomal drug products

#137
20230173082
2023-06-08

ANTIBACTERIAL PRODUCTS

#138
20230158101
2023-05-25

Glycopeptide compositions

#139
20230149340
2023-05-18

BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS

#140
20230149297
2023-05-18

Antibiotic formulations for lower back pain

#141
20230126007
2023-04-27

NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS

#142
20230123585
2023-04-20

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CANCER USING DEUBIQUITINASE INHIBITORS

#143
20230122049
2023-04-20

METHOD AND COMBINATION FOR THE SUPPRESSION OF COVID-19 VIRUS

#144
20230113554
2023-04-13

NON-STICK ANTIBIOTIC GELS

#145
20230105381
2023-04-06

COMPOSITIONS AND METHODS FOR BIOORTHOGONAL SURFACE COATING

#146
20230102830
2023-03-30

Composition and method for vancomycin oral liquid

#147
20230097743
2023-03-30

IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY INTO IMMUNE CELLS

#148
20230079757
2023-03-16

METHODS AND MATERIALS FOR TREATING CANCER

#149
20230079407
2023-03-16

ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF

#150
20230059851
2023-02-23

Implantable cellular and biotherapeutic agent delivery canister

#151
20230044467
2023-02-09

GLYCOPEPTIDE ANTIBIOTIC COMBINATION THERAPY

#152
20230041385
2023-02-09

HER2 MUTATION INHIBITORS

#153
20230035422
2023-02-02

METHODS FOR TREATING DISEASES BY TARGETING ONCOGENIC LIPIDS

#154
20220409542
2022-12-29

Inhalable antimicrobial particles and methods of making the same

#155
20220401554
2022-12-22

USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES

#156
20220401487
2022-12-22

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES

#157
20220401471
2022-12-22

Implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin and gentamicin

#158
20220387395
2022-12-08

UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION

#159
20220387308
2022-12-08

Pharmaceutical ophthalmic compositions

#160
20220378877
2022-12-01

TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS

#161
20220378804
2022-12-01

Compositions and methods of clostridiodides difficile treatment, decolonization, and prevention

#162
20220370622
2022-11-24

Pharmaceutical compositions and related methods of delivery

#163
20220370621
2022-11-24

Pharmaceutical compositions and related methods of delivery

#164
20220362329
2022-11-17

TREATING ACUTE LIVER DISEASE WITH TLR-MIK INIHIBITORS

#165
20220354927
2022-11-10

Glycopeptide compositions

#166
20220354925
2022-11-10

METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS

#167
20220354902
2022-11-10

Methods of generating, repairing and/or maintaining connective tissue in vivo

#168
20220332774
2022-10-20

THERAPEUTIC MITOCHONDRIAL PEPTIDES

#169
20220323383
2022-10-13

SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF

#170
20220313830
2022-10-06

HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF

#171
20220313748
2022-10-06

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HPV-RELATED CANCER

#172
20220296515
2022-09-22

Vancomycin Liposome Compositions and Methods

#173
20220288166
2022-09-15

MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF

#174
20220288158
2022-09-15

NOVEL ENTERIC COMBINATION THERAPY

#175
20220273586
2022-09-01

RATIONALLY DESIGNED LAWSONE DERIVATIVES AS ANTIMICROBIALS AGAINST MULTIDRUG-RESISTANT STAPHYLOCOCCUS AUREUS

#176
20220257514
2022-08-18

MONOSACCHARIDE-TAGGED NANO-LIPOSOME DRUG DELIVERY SYSTEM, THE MANUFACTURE AND USE FOR DRUG TARGETING DELIVERY THEREOF

#177
20220251175
2022-08-11

Compositions and methods for treating and preventing infections

#178
20220249660
2022-08-11

COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER

#179
20220249485
2022-08-11

TOPICAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME

#180
20220241368
2022-08-04

PERCUTANEOUS ANTI-MICROBIOTA FORMULATIONS

#181
20220241249
2022-08-04

PHARMACEUTICAL COMPOSITION AND KIT CONTAINING NOVEL PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED FROM beta-LACTAMASE INHIBITORY COMPOUND AND ANTIBACTERIAL COMPOUND OR SALTS THEREOF

#182
20220233649
2022-07-28

ORAL ADMINISTRATION OF UNSTABLE OR POORLY-ABSORBED DRUGS

#183
20220226429
2022-07-21

Enteric combination therapy

#184
20220211676
2022-07-07

COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES

#185
20220211637
2022-07-07

RANDOM COPOLYMER STABILIZED NANOPARTICLES ENCAPSULATING SOLUBLE HYDROPHILIC COMPOUNDS

#186
20220204604
2022-06-30

METHODS AND COMPOSITIONS FOR TREATING CANCER

#187
20220193149
2022-06-23

COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE DRUG DELIVERY

#188
20220193067
2022-06-23

QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA

#189
20220184173
2022-06-16

STABLE PHARMACEUTICAL FORMULATIONS OF PEPTIDE AND PROTEIN DRUGS

#190
20220183997
2022-06-16

USE OF CANNABIDIOL IN COMBINATION WITH ANTIBIOTICS

#191
20220177954
2022-06-09

NUCLEIC ACID PROBES

#192
20220175741
2022-06-09

COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM

#193
20220160842
2022-05-26

METHOD OF TREATING INFECTIVE ENDOCARDITIS

#194
20220151982
2022-05-19

CANNABINOID COMPOSITIONS AND USE THEREOF

#195
20220143053
2022-05-12

ANTI-MICROBIAL METHODS AND MATERIALS

#196
20220142988
2022-05-12

Materials and Methods for Enhanced Treatment and Prevention of Biofilms

#197
20220142916
2022-05-12

Implantable cellular and biotherapeutic agent delivery canister

#198
20220135528
2022-05-05

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#199
20220134341
2022-05-05

Fluidic device for the detection, capture, or removal of a disease material

#200
20220133845
2022-05-05

Glycopeptide antibiotics liquid formulations and methods and uses thereof

#201
20220133844
2022-05-05

GLYCOPEPTIDE ANTIBIOTICS LIQUID FORMULATIONS AND METHODS AND USES THEREOF

#202
20220133843
2022-05-05

Lipo-glycopeptide cleavable derivatives and uses thereof

#203
20220125903
2022-04-28

METHODS FOR IMPROVING THE EFFICACY OF A SURVIVIN THERAPEUTIC IN THE TREATMENT OF TUMORS

#204
20220125763
2022-04-28

COMPOSITIONS PROVIDING ENHANCED ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA AND USE THEREOF

#205
20220096492
2022-03-31

Pharmaceutical compounds and therapeutic methods

#206
20220096465
2022-03-31

USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY

#207
20220088089
2022-03-24

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#208
20220047733
2022-02-17

Heating apparatus and methods

#209
20220047704
2022-02-17

Inactivating bacteria with electric pulses and antibiotics

#210
20220047584
2022-02-17

Method of local antibiotic treatment of infective endocarditis

#211
20220040156
2022-02-10

COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER

#212
20220040116
2022-02-10

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

#213
20220023419
2022-01-27

INHIBITING INFLAMMATION

#214
20220023399
2022-01-27

BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF

#215
20220016200
2022-01-20

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS

#216
20220016132
2022-01-20

BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES

#217
20220000991
2022-01-06

CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME

#218
20220000940
2022-01-06

Compositions and methods for treating epilepsy and related disorders

#219
20220000884
2022-01-06

TREATMENT AND PREVENTION OF CLOSTRIDIUM DIFFICILE COLITIS USING MISOPROSTOL

#220
20220000864
2022-01-06

MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)

#221
20210401815
2021-12-30

RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA

#222
20210393735
2021-12-23

PHARMACEUTICAL COMPOSITION COMPRISING TEICOPLANIN

#223
20210393554
2021-12-23

NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY

#224
20210386839
2021-12-16

Vaccine adjuvants and formulations

#225
20210361741
2021-11-25

NANOPARTICLE FORMULATIONS AND METHODS OF USE FOR ALPHA CONNEXIN C-TERMINAL PEPTIDES

#226
20210353758
2021-11-18

MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR

#227
20210346502
2021-11-11

Processes for preparing functionalized cyclooctenes

#228
20210346368
2021-11-11

ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS

#229
20210338815
2021-11-04

COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING

#230
20210338678
2021-11-04

BIOACTIVE VITAMIN COMBINATIONS

#231
20210330712
2021-10-28

Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells

#232
20210330645
2021-10-28

ANTIBACTERIAL COMBINATIONS

#233
20210315950
2021-10-14

Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy

#234
20210315869
2021-10-14

COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR

#235
20210309731
2021-10-07

Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof

#236
20210308451
2021-10-07

METHOD AND DEVICE FOR TREATING MICROSCOPIC RESIDUAL TUMORS REMAINING IN TISSUES FOLLOWING SURGICAL RESECTION

#237
20210290697
2021-09-23

Methods of preventing and treating COVID-19 infection with probiotics

#238
20210283107
2021-09-16

Methods to Expand the Spectrum of Gram-Positive Antibiotics

#239
20210283060
2021-09-16

Fine nano-sized medicinal agent and use thereof

#240
20210282933
2021-09-16

Drug-Eluting Spacer for Joints of the Human Body

#241
20210275507
2021-09-09

Methods of treating hepatic encephalopathy

#242
20210275483
2021-09-09

Bactericidal debridement compositions for surgical site infections and chronic wound healing

#243
20210275440
2021-09-09

MICROBEAD COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT

#244
20210267992
2021-09-02

5-ACETAMIDOMETHYL-OXAZOLIDINONE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER

#245
20210267978
2021-09-02

NANOPARTICLE FORMULATIONS OF IKE AND METHODS OF USE THEREOF

#246
20210260213
2021-08-26

METHODS AND COMPOSITIONS FOR DELIVERY OF A THERAPEUTIC AGENT

#247
20210260017
2021-08-26

Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications

#248
20210244752
2021-08-12

PH-responsive polymer-drug conjugates for enhanced antibacterial efficacy

#249
20210236592
2021-08-05

Formulations of vancomycin

#250
20210236466
2021-08-05

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#251
20210228736
2021-07-29

PATHOGEN CONTROL COMPOSITIONS AND USES THEREOF

#252
20210228735
2021-07-29

Hydrogel compositions

#253
20210228734
2021-07-29

Conjugates comprising a temperature-responsive polymer and a ligand capable of binding ergosterol

#254
20210228607
2021-07-29

Pharmaceutical composition for prevention or treatment of flavivirus infection

#255
20210221936
2021-07-22

MESOPOROUS ELASTOMER

#256
20210221888
2021-07-22

Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

#257
20210220452
2021-07-22

Microbiome protection from oral antibiotics

#258
20210220433
2021-07-22

Glycopeptide compositions

#259
20210213134
2021-07-15

THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS

#260
20210213131
2021-07-15

Treatment for reducing adverse events including chemotherapy discomfort and other conditions

#261
20210213096
2021-07-15

MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS

#262
20210205407
2021-07-08

Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same

#263
20210188977
2021-06-24

Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

#264
20210187061
2021-06-24

Enteric combination therapy

#265
20210169799
2021-06-10

COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID

#266
20210154264
2021-05-27

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS

#267
20210154137
2021-05-27

DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS

#268
20210138028
2021-05-13

Treating or preventing adverse liver conditions

#269
20210128696
2021-05-06

BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA

#270
20210128454
2021-05-06

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

#271
20210113699
2021-04-22

Compositions and methods for delivering an agent to a wound

#272
20210113651
2021-04-22

Antimicrobial articles produced by additive manufacturing

#273
20210106671
2021-04-15

TREATMENT AND PREVENTION OF PLANTAR WARTS

#274
20210106670
2021-04-15

TREATMENT AND PREVENTION OF GENITAL WARTS

#275
20210100787
2021-04-08

Diiodohydroxyquinoline for the treatment of clostridium difficile infection

#276
20210093691
2021-04-01

Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof

#277
20210077570
2021-03-18

COMPOSITION COMPRISING A POLYMYXIN AND TEICOPLANIN

#278
20210060188
2021-03-04

TCO conjugates and methods for delivery of therapeutic agents

#279
20210059934
2021-03-04

Methods and compositions for treating diabetic foot ulcers

#280
20210046001
2021-02-18

Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof

#281
20210038592
2021-02-11

Pharmaceutical compositions for intraocular administration and methods for fabricating thereof

#282
20210038515
2021-02-11

COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID

#283
20210030836
2021-02-04

Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor

#284
20210030711
2021-02-04

Nasal drug delivery device and method of making same

#285
20210023011
2021-01-28

METHOD AND SYSTEM FOR PRODUCING HIGH PURITY VANCOMYCIN HYDROCHLORIDE

#286
20210023002
2021-01-28

COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID

#287
20210015889
2021-01-21

METHODS OF DISRUPTING A BIOFILM AND/OR PREVENTING FORMATION OF SAME

#288
20210015888
2021-01-21

Supramolecular glycosaminoglycans

#289
20210015866
2021-01-21

TISSUE RESIDENT MEMORY CELL PROFILES, AND USES THEREOF

#290
20210015750
2021-01-21

Methods for continuous manufacture of liposomal drug products

#291
20210008175
2021-01-14

BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA

#292
20200397906
2020-12-24

Pharmaceutical compositions and related methods of delivery

#293
20200397738
2020-12-24

METHODS FOR TREATING CANCER AND PROTECTING RENEWABLE TISSUES

#294
20200384092
2020-12-10

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

#295
20200377463
2020-12-03

Macrocyclic broad spectrum antibiotics

#296
20200376046
2020-12-03

PROBIOTIC RECOLONISATION THERAPY

#297
20200368351
2020-11-26

Inactivating bacteria with electric pulses and antibiotics

#298
20200368313
2020-11-26

DRUG DELIVERY SYSTEMS FOR TREATMENT OF INFECTIONS

#299
20200368312
2020-11-26

GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF

#300
20200368213
2020-11-26

METHODS OF TREATING HEPATIC ENCEPHALOPATHY